Literature DB >> 33034860

Liver Injury Associated with the Selective Progesterone Modulator Ulipristal.

Einar S Björnsson1,2.   

Abstract

Entities:  

Year:  2020        PMID： 33034860     DOI： 10.1007/s40264-020-01004-4

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  2 in total

1.  An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids.

Authors:  Sarah Kang; Allen Brinker; S Christopher Jones; Lara Dimick-Santos; Mark I Avigan
Journal:  Drug Saf       Date:  2020-12       Impact factor: 5.606

2.  Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.

Authors:  Milo Gatti; Elisabetta Poluzzi; Fabrizio De Ponti; Emanuel Raschi
Journal:  Drug Saf       Date:  2020-12       Impact factor: 5.606
  2 in total
  1 in total

Review 1.  Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.

Authors:  Mohamed Ali; Mohamed Raslan; Michał Ciebiera; Kornelia Zaręba; Ayman Al-Hendy
Journal:  Expert Opin Drug Saf       Date:  2021-10-20       Impact factor: 4.250
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.